NASDAQ
HAVN Life Sciences Inc. (HAVLF) has a free cash flow growth of 151.81% as of Friday, May 29, 2026. This represents a 415.66% increase compared to its 12-month average of 29.44%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.